Skip to content

Drug interactions

Ipratropium-salbutamol + Rilpivirine

Severity: Minor

Ipratropium-salbutamol and Rilpivirine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rilpivirine can prolong the QT interval at supratherapeutic doses, and salbutamol may add to arrhythmic risk through hypokalemia and tachycardia. The clinical risk at standard doses is small but greater in patients with other QT risk factors.

What this interaction means in plain words

Ipratropium-salbutamol and Rilpivirine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ipratropium-salbutamol belongs to Respiratory; Rilpivirine belongs to Anti Virals.

Evidence level: Low

Why it happens

Potential additive QT prolongation and beta-2 agonist-induced hypokalemia.

What to do

No routine action is needed at usual doses. Check ECG and electrolytes if other QT-prolonging risks are present.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ipratropium-salbutamol and Rilpivirine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ipratropium-salbutamol with Rilpivirine?

MediHelp rates the interaction as minor. Ipratropium-salbutamol and Rilpivirine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Rilpivirine can prolong the QT interval at supratherapeutic doses, and salbutamol may add to arrhythmic risk through hypokalemia and tachycardia. The clinical risk at standard doses is small but greater in patients with other QT risk factors.

How serious is the interaction between Ipratropium-salbutamol and Rilpivirine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine action is needed at usual doses. Check ECG and electrolytes if other QT-prolonging risks are present.

What other medicines interact with Ipratropium-salbutamol?

MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in